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Introduction
Abstract
Bone constantly cycles through a dynamic process of breakdown and 
remodeling. Osteoblasts are the specialized mesenchymal stem cells that have 
a major role in bone formation and the remodeling process whereas their 
counterpart osteoclasts, handle bone resorption. Embryonic stem cells can be 
partially differentiated into Progenitor cells, and we worked with #18, a 
candidate for being an osteoprogenitor that has the potential to respond to 
morphogenic activators. In the case of bone remodeling, TGF-β 2, BMP-2 and 
an abundance of CA++ have been shown to be potential activators of 
differentiation into osteoblasts. Eight different trials were conducted with the 
cells using different combinations of the three morphogenic activators. After 
inducing the cells with the activators, we performed Immunohistochemistry 
(IHC) to analyze the expression of osteocalcin, which is the enzyme that binds 
calcium to mineralize bone. The cells with varying activator combinations 
showed different physiology with a variance in the cell shape, structure, and 
spacing. The greatest results were from the combination of TGF-β 2 and 
BMP-2, which is consistent with #18 operating as an osteoprogenitor. A 3D 
construct model of  #18 seemed to have a similar structure to that of an osteon, 
possibly indicating the formation of bone. We took slices of the model and 
performed an IHC staining for Osteocalcin, Prolyl Hydroxylase (5B5), and 
Collagen I. We saw a strong positive signal for Col I and 5B5, and a slight 
positive signal for Osteocalcin. This information confirmed that #18 is an 
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• Human Embryonic Stem Cells can be partially differentiated 
into progenitor cell lines. We chose #18 as a candidate for 
the formation of osteoblasts.  
• We tested factors that trigger Osteoblast formation and saw 
that the combination of TGFB-2, BMP-2 was successful.  
• We conclude that cell line #18 is an osteoprogenitor with the 
potential to assemble bone. Cell Culture 
• A P-60 culture of Human embryonic Progenitor line # 18 was used from BioTime. 
• The culture was grown in DMEM 10 % FBS medium and treated to a 5ml PBS followed by Trypsin. 
• After centrifugation cell line was divided evenly into an 8 well slide each individual well was 
exposed to a combination of three morphogenic activators: BMP-2 (10 uL), TGF-β2 (10 uL), and Ca 
++ (2.5 uL) 
• After 4 days of incubation images were taken for morphology and culture was returned to 37° C 
incubator 
Cell Culture Immunohistochemistry (IHC) 
• 7 days after adding morphogenic activators, IHC was conducted. 
• Cell were separated, marked by pap-pen and fixed to slide using Acetone methanol solution for 10 
minutes at room temperature. 
• Cells were stained for 50 minutes with a 1:200 dilution of primary antibodies, Osteocalcin and 
Collagen I    
• A second antibody was used at a 1:200 dilution of goat antimouse IgG 594 Red. 
• Cell culture was examined by conventional fluorescent microscope (Axiovert 40 CFL) with images 
taken from Nikon D600 
3D Construct Immunohistochemistry (IHC) 
• 3D model, created by the progenitor line, was sectioned by a cryostat  
• Slices were taken and placed on glass slides to be observed with  a microscope 
• Two different slides were divided up  and stained for 50 minutes. 
• Slide 1 was stained with Osteocalcin 
• Slide 2 was stained with Collagen I
Figure 1: Changing morphology in response to morphogenic activators in #18 (40x)  
P60 plate of line #18 in the presence of morphological activators resulted in clear morphological changes. (A) The 
control line shows the normal morphology of line #18. (B) Cells induced with BMP-2 began to spread out and 
become confluent. (C) Cells induced with TGF-β 2 began to cluster more after induction. (D) The cells treated with a 
combination of BMP-2 and TGF-β 2 presented as larger aggregates.  
Figure 2: Collagen Expressed in 3D Model (40X) 
After taking slices of the 3D model, immunohistochemistry was 
performed to characterize the expression of Collagen I. (A) The DAPI 
stain presents expression of Collagen I (B) Collagen I does not 
completely overlap the nuclei signaling that collagen is made in the 
vicinity of the cells.
Figure 3: Osteocalcin Expressed in 3D Model (40X)  
After taking slices of the 3D model, immunohistochemistry was 
performed to characterize the expression of Osteocalcin. (A) The DAPI 
stain expresses a positive expression for Osteocalcin. (B) IHC shows 
Osteocalcin does not completely overlap with the nuclei and is secreting 
osteoid beyond the boundaries of the cell, forming bone.
Figure 4: Progentior cells induced with BMP-2 and TGFB-2 express 
Osteocalcin  
(A) Blue dots show DAPI staining of nuclei therefore the position of 
living cells. (B) Red staining shows that IHC staining was positive for 
Osteocalcin. 
Figure 5: Embryonic Stem 
Cell (ESC) Differentiation to 
Bone Cells 
Our collaborator “BioTime inc” 
took ESCs and derived 
Mesenchymal Stem Cells 
(MSC) #18. We tested to see 
if these cells could be 
manipulated into becoming 
bone cells (osteoblasts) by 
adding BMP-2 and TGFB-2. 
We saw Collagen 1 and 
Osteocalcin in IHC which 
indicates positive bone cell 
formation. 
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Human embryonic stem cells (hESC) are primordial, unspecialized 
cells that can differentiate into any other cell type. BioTime’s business 
is to direct these hESC into progenitor cell lines with the potential to 
become differentiated into a variety of different cell types. One of 
Biotime’s cell lines, progenitor # 18, is a Mesenchymal stem cell (MSC) 
line. Specialized MSC’s can be potentially differentiated into muscle, 
tendons, ligaments, fat, and bone. MSC’s are sensitive to the timing of 
growth factor presentation and differentiation can be specialized 
toward osteoprogenitors responsible for bone formation and 
remodeling. We encompassed our research around the question of 
whether Progenitor #18 cells have the potential to be differentiated into 
primary bone cells called osteoblasts. Osteoblasts distinguish 
themselves from other mesenchymal cells through the production of 
osteocalcin, which is responsible for the calcification of bone. This 
research could advance efforts in the field of bone repair.  
